RESUMEN
DCBLD2 encodes discodin, CUB and LCCL domain-containing protein 2, a type-I transmembrane receptor that is involved in intracellular receptor signalling pathways and the regulation of cell growth. In this report, we describe a 5-year-old female who presented severe clinical features, including restrictive cardiomyopathy, developmental delay, spasticity and dysmorphic features. Trio-whole-exome sequencing and segregation analysis were performed to identify the genetic cause of the disease within the family. A novel homozygous nonsense variant in the DCBLD2 gene (c.80G > A, p.W27*) was identified as the most likely cause of the patient's phenotype. This nonsense variant falls in the extracellular N-terminus of DCBLD2 and thus might affect proper protein function of the transmembrane receptor. A number of in vitro investigations were performed on the proband's skin fibroblasts compared to normal fibroblasts, which allowed a comprehensive assessment resulting in the functional characterization of the identified DCBLD2 nonsense variant in different cellular processes. Our data propose a significant association between the identified variant and the observed reduction in cell proliferation, cell cycle progression, intracellular ROS, and Ca2 + levels, which would likely explain the phenotypic presentation of the patient as associated with lethal restrictive cardiomyopathy.
Asunto(s)
Anomalías Múltiples/genética , Cardiomiopatía Restrictiva/genética , Codón sin Sentido , Discapacidades del Desarrollo/genética , Predisposición Genética a la Enfermedad , Homocigoto , Proteínas de la Membrana/genética , Anomalías Múltiples/diagnóstico , Alelos , Calcio/metabolismo , Cardiomiopatía Restrictiva/diagnóstico , Cardiomiopatía Restrictiva/metabolismo , Ciclo Celular/genética , Preescolar , Consanguinidad , Discapacidades del Desarrollo/diagnóstico , Discapacidades del Desarrollo/metabolismo , Facies , Femenino , Estudios de Asociación Genética/métodos , Genoma Mitocondrial , Genómica/métodos , Humanos , Angiografía por Resonancia Magnética , Fenotipo , Radiografía Torácica , Especies Reactivas de Oxígeno/metabolismo , Secuenciación del ExomaRESUMEN
UDP-glucose dehydrogenase (UGDH) encodes an oxidoreductase that converts two successive oxidations of UDP-glucose to produce UDP-glucuronic acid, a key component in the synthesis of several polysaccharides such as glycosaminoglycan and the disaccharide hyaluronic acid. UGDH is critical to the production of extracellular matrix components which are essential to the migration and connectivity of neurons early in human brain development. In this report, we describe one child of a consanguineous family who presented with distinct clinical features including global developmental delay, axial hypotonia, bilateral undescended testis, and subtle dysmorphic features. Whole genome sequencing and a segregation was performed to identify the genetic cause of the disease within the family. Though mutations in the UGDH protein have been described as causing developmental delay in various model organisms, to our knowledge, this is the first identification of the novel homozygous missense variant in exon8 of UGDH NM_003359.3: c.950 G>A (p.Arg317Gln) and most likely the cause of the patient's phenotype. This variant falls in an active region and replaces the highly conserved Arginine 317 residues across mammals.